Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Killer Cells, Natural | 17 | 2022 | 2133 | 3.410 |
Why?
|
Head and Neck Neoplasms | 26 | 2023 | 2706 | 3.390 |
Why?
|
Receptors, Aryl Hydrocarbon | 4 | 2021 | 207 | 2.090 |
Why?
|
Carcinoma, Squamous Cell | 21 | 2023 | 4014 | 2.000 |
Why?
|
Mouth Neoplasms | 7 | 2023 | 601 | 1.600 |
Why?
|
Receptors, Nerve Growth Factor | 3 | 2018 | 200 | 1.070 |
Why?
|
Immunity, Innate | 3 | 2021 | 2950 | 0.950 |
Why?
|
Lymphocyte Subsets | 2 | 2021 | 315 | 0.820 |
Why?
|
Tumor Microenvironment | 11 | 2023 | 3508 | 0.810 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2021 | 174 | 0.730 |
Why?
|
Immunotherapy | 8 | 2023 | 4391 | 0.710 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 2022 | 284 | 0.710 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2016 | 48 | 0.590 |
Why?
|
Neoplasms, Experimental | 4 | 2018 | 1280 | 0.580 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 311 | 0.580 |
Why?
|
Infant, Premature, Diseases | 1 | 2022 | 704 | 0.560 |
Why?
|
Lymphocytes | 2 | 2021 | 2612 | 0.560 |
Why?
|
Thyroid Diseases | 1 | 2019 | 378 | 0.540 |
Why?
|
Neoplastic Stem Cells | 2 | 2014 | 1380 | 0.520 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1116 | 0.510 |
Why?
|
Microvessels | 4 | 2020 | 544 | 0.470 |
Why?
|
Neoplasm Invasiveness | 5 | 2018 | 3603 | 0.470 |
Why?
|
Lymphatic System | 1 | 2015 | 253 | 0.470 |
Why?
|
Sentinel Lymph Node Biopsy | 3 | 2024 | 699 | 0.470 |
Why?
|
Nerve Tissue Proteins | 3 | 2018 | 4463 | 0.460 |
Why?
|
Melanoma | 7 | 2024 | 5446 | 0.460 |
Why?
|
Proteoglycans | 1 | 2016 | 835 | 0.450 |
Why?
|
Histones | 1 | 2023 | 2591 | 0.440 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 16646 | 0.440 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 354 | 0.440 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1239 | 0.440 |
Why?
|
Vasoconstriction | 4 | 2020 | 601 | 0.430 |
Why?
|
Cell Movement | 5 | 2021 | 5221 | 0.420 |
Why?
|
Skin Neoplasms | 8 | 2024 | 5632 | 0.420 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2020 | 9122 | 0.410 |
Why?
|
Microcirculation | 2 | 2020 | 1285 | 0.410 |
Why?
|
Cerebral Hemorrhage | 2 | 2022 | 2627 | 0.400 |
Why?
|
Cell Adhesion Molecules | 1 | 2018 | 1599 | 0.400 |
Why?
|
Molecular Targeted Therapy | 3 | 2018 | 2727 | 0.400 |
Why?
|
Antigens, CD | 2 | 2021 | 4024 | 0.390 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1702 | 0.380 |
Why?
|
Anemia, Sickle Cell | 4 | 2020 | 1015 | 0.370 |
Why?
|
Immune System | 1 | 2015 | 801 | 0.360 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2011 | 268 | 0.340 |
Why?
|
Cerebrovascular Circulation | 4 | 2022 | 2757 | 0.310 |
Why?
|
Neoplasms | 7 | 2022 | 21507 | 0.300 |
Why?
|
Maxillary Artery | 1 | 2007 | 19 | 0.300 |
Why?
|
Mice | 23 | 2023 | 81002 | 0.300 |
Why?
|
Antibodies, Monoclonal | 4 | 2015 | 9259 | 0.300 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2023 | 4424 | 0.300 |
Why?
|
Antigens, Neoplasm | 2 | 2014 | 1977 | 0.300 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8400 | 0.280 |
Why?
|
Aneurysm, Infected | 1 | 2007 | 85 | 0.280 |
Why?
|
Animals | 31 | 2023 | 168368 | 0.280 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2517 | 0.270 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5522 | 0.270 |
Why?
|
NF-kappa B | 6 | 2022 | 2502 | 0.260 |
Why?
|
Humans | 75 | 2024 | 739398 | 0.260 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 997 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3143 | 0.260 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18003 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3248 | 0.260 |
Why?
|
Organoids | 2 | 2021 | 687 | 0.240 |
Why?
|
Aneurysm, False | 1 | 2007 | 275 | 0.240 |
Why?
|
Cell Growth Processes | 2 | 2015 | 399 | 0.240 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1029 | 0.240 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2023 | 666 | 0.240 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1497 | 0.230 |
Why?
|
Genes, cdc | 1 | 2023 | 117 | 0.230 |
Why?
|
Spectrum Analysis | 2 | 2022 | 450 | 0.230 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2016 | 3562 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8274 | 0.220 |
Why?
|
Gastrointestinal Agents | 1 | 2008 | 494 | 0.220 |
Why?
|
Cell Differentiation | 4 | 2021 | 11460 | 0.220 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2023 | 705 | 0.220 |
Why?
|
Sotos Syndrome | 1 | 2022 | 10 | 0.220 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 70 | 0.200 |
Why?
|
alpha-Globins | 1 | 2020 | 17 | 0.200 |
Why?
|
Vascular Diseases | 2 | 2020 | 1152 | 0.200 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1618 | 0.190 |
Why?
|
alpha-Thalassemia | 1 | 2020 | 46 | 0.190 |
Why?
|
Liver | 1 | 2016 | 7449 | 0.190 |
Why?
|
Primary Dysautonomias | 1 | 2020 | 25 | 0.190 |
Why?
|
Interleukin-15 | 1 | 2021 | 182 | 0.190 |
Why?
|
Electrons | 1 | 2021 | 269 | 0.180 |
Why?
|
Fiber Optic Technology | 1 | 2022 | 287 | 0.180 |
Why?
|
Homeodomain Proteins | 2 | 2013 | 2409 | 0.180 |
Why?
|
Mice, Inbred BALB C | 5 | 2018 | 6397 | 0.180 |
Why?
|
Interferon Type I | 1 | 2023 | 541 | 0.170 |
Why?
|
Hyperemia | 1 | 2020 | 224 | 0.170 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 302 | 0.170 |
Why?
|
Chemokines | 1 | 2023 | 948 | 0.170 |
Why?
|
Chemokines, CXC | 1 | 2020 | 422 | 0.170 |
Why?
|
Lymph Nodes | 4 | 2024 | 3454 | 0.160 |
Why?
|
Cranial Nerves | 1 | 2018 | 97 | 0.160 |
Why?
|
Laryngectomy | 1 | 2020 | 244 | 0.160 |
Why?
|
Thyroid Neoplasms | 3 | 2021 | 2267 | 0.160 |
Why?
|
Models, Immunological | 2 | 2018 | 527 | 0.150 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 2015 | 301 | 0.150 |
Why?
|
Hypoparathyroidism | 1 | 2018 | 120 | 0.150 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9387 | 0.150 |
Why?
|
Integrin alpha1 | 1 | 2016 | 13 | 0.150 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.150 |
Why?
|
Integrin alpha2 | 1 | 2016 | 40 | 0.140 |
Why?
|
Arterioles | 1 | 2017 | 253 | 0.140 |
Why?
|
Thyroidectomy | 2 | 2021 | 876 | 0.140 |
Why?
|
Temperature | 2 | 2020 | 2202 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5148 | 0.140 |
Why?
|
Vasodilation | 1 | 2020 | 947 | 0.140 |
Why?
|
Boronic Acids | 2 | 2015 | 966 | 0.140 |
Why?
|
Appointments and Schedules | 1 | 2020 | 415 | 0.140 |
Why?
|
Tracheostomy | 1 | 2020 | 402 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4400 | 0.140 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 21863 | 0.140 |
Why?
|
Microscopy | 1 | 2021 | 899 | 0.140 |
Why?
|
Ubiquitination | 1 | 2021 | 1003 | 0.140 |
Why?
|
Dermatitis, Contact | 1 | 2016 | 129 | 0.140 |
Why?
|
Cytokines | 6 | 2023 | 7298 | 0.140 |
Why?
|
Luminescence | 1 | 2016 | 136 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 566 | 0.140 |
Why?
|
Carcinoma | 4 | 2016 | 2361 | 0.130 |
Why?
|
Beta Particles | 1 | 2015 | 50 | 0.130 |
Why?
|
Nerve Growth Factor | 1 | 2016 | 148 | 0.130 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 197 | 0.130 |
Why?
|
Zymosan | 1 | 2015 | 124 | 0.130 |
Why?
|
Ameloblastoma | 1 | 2015 | 44 | 0.130 |
Why?
|
Pyrazines | 2 | 2015 | 1232 | 0.130 |
Why?
|
Peripheral Nerves | 1 | 2018 | 481 | 0.130 |
Why?
|
Jaw Neoplasms | 1 | 2015 | 74 | 0.130 |
Why?
|
STAT1 Transcription Factor | 1 | 2016 | 319 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 744 | 0.120 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1331 | 0.120 |
Why?
|
Cells, Cultured | 4 | 2018 | 19220 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 554 | 0.120 |
Why?
|
Guanosine Triphosphate | 1 | 2015 | 320 | 0.120 |
Why?
|
Ulcer | 1 | 2015 | 205 | 0.120 |
Why?
|
Pain | 3 | 2018 | 4923 | 0.120 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 247 | 0.120 |
Why?
|
Gestational Age | 1 | 2022 | 3486 | 0.120 |
Why?
|
Computers, Handheld | 1 | 2015 | 210 | 0.120 |
Why?
|
Infant, Newborn | 6 | 2022 | 25470 | 0.110 |
Why?
|
Phenotype | 3 | 2021 | 16301 | 0.110 |
Why?
|
RNA Interference | 3 | 2017 | 2899 | 0.110 |
Why?
|
Artifacts | 1 | 2022 | 1905 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2015 | 405 | 0.110 |
Why?
|
Oral Surgical Procedures | 1 | 2015 | 168 | 0.110 |
Why?
|
Lung Neoplasms | 2 | 2017 | 12985 | 0.110 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2013 | 149 | 0.110 |
Why?
|
Prognosis | 9 | 2024 | 28901 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13635 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2018 | 543 | 0.110 |
Why?
|
Herpesvirus 4, Human | 2 | 2022 | 1038 | 0.110 |
Why?
|
Infant, Premature | 1 | 2022 | 2039 | 0.110 |
Why?
|
Lymphatic Metastasis | 4 | 2023 | 2897 | 0.110 |
Why?
|
Blood Flow Velocity | 2 | 2021 | 1437 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2901 | 0.110 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 891 | 0.110 |
Why?
|
Female | 26 | 2023 | 378853 | 0.110 |
Why?
|
Immunomagnetic Separation | 1 | 2012 | 80 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1867 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2503 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2021 | 2026 | 0.100 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10142 | 0.100 |
Why?
|
Pharyngectomy | 1 | 2011 | 45 | 0.100 |
Why?
|
Brain | 5 | 2022 | 26345 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2020 | 2121 | 0.100 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1654 | 0.100 |
Why?
|
Transcription Factors | 3 | 2021 | 12120 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 875 | 0.100 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6361 | 0.100 |
Why?
|
Program Evaluation | 1 | 2020 | 2484 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1585 | 0.100 |
Why?
|
Multienzyme Complexes | 1 | 2015 | 687 | 0.100 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 2028 | 0.100 |
Why?
|
Genes, Viral | 1 | 2012 | 719 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2018 | 13002 | 0.100 |
Why?
|
Australia | 2 | 2024 | 1162 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 3498 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2021 | 0.090 |
Why?
|
Male | 22 | 2021 | 349022 | 0.090 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4832 | 0.090 |
Why?
|
Chromatin | 1 | 2021 | 2848 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20055 | 0.090 |
Why?
|
Biomimetics | 1 | 2011 | 171 | 0.090 |
Why?
|
Survival Analysis | 3 | 2017 | 10247 | 0.090 |
Why?
|
Palliative Care | 2 | 2022 | 3461 | 0.090 |
Why?
|
Patient Readmission | 1 | 2023 | 3106 | 0.090 |
Why?
|
Electronics | 1 | 2011 | 322 | 0.090 |
Why?
|
Seizures | 1 | 2022 | 2829 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2012 | 582 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 925 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 625 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2217 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2018 | 10961 | 0.080 |
Why?
|
Receptors, KIR3DL1 | 1 | 2008 | 22 | 0.080 |
Why?
|
Quality of Life | 2 | 2023 | 12640 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 2084 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 1008 | 0.080 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2008 | 45 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2259 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2015 | 1023 | 0.080 |
Why?
|
DNA Methylation | 2 | 2022 | 4269 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4211 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1522 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2022 | 3844 | 0.080 |
Why?
|
Prostatectomy | 1 | 2016 | 1858 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1834 | 0.070 |
Why?
|
Antibodies | 2 | 2012 | 2450 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2116 | 0.070 |
Why?
|
Mice, SCID | 1 | 2012 | 2716 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2021 | 57650 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3770 | 0.070 |
Why?
|
Retrospective Studies | 10 | 2024 | 76631 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2008 | 352 | 0.070 |
Why?
|
Phosphorylation | 2 | 2015 | 8416 | 0.070 |
Why?
|
MicroRNAs | 2 | 2020 | 3712 | 0.070 |
Why?
|
Data Collection | 1 | 2015 | 3341 | 0.070 |
Why?
|
Activating Transcription Factor 2 | 1 | 2005 | 46 | 0.070 |
Why?
|
Infant | 3 | 2022 | 34923 | 0.070 |
Why?
|
Middle Aged | 13 | 2021 | 212863 | 0.070 |
Why?
|
Aged | 11 | 2021 | 162698 | 0.070 |
Why?
|
Mice, Knockout | 1 | 2021 | 14558 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1890 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2012 | 1424 | 0.070 |
Why?
|
Homeostasis | 1 | 2016 | 3348 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2017 | 3609 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1269 | 0.060 |
Why?
|
Adult | 15 | 2021 | 213394 | 0.060 |
Why?
|
Immune Tolerance | 2 | 2022 | 2256 | 0.060 |
Why?
|
Signal Transduction | 5 | 2022 | 23355 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5863 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2910 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2381 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2936 | 0.060 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1735 | 0.060 |
Why?
|
Gene Expression | 3 | 2022 | 7788 | 0.060 |
Why?
|
Glutaminase | 1 | 2023 | 34 | 0.060 |
Why?
|
Autonomic Nervous System | 2 | 2019 | 670 | 0.060 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 656 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2016 | 5012 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5830 | 0.050 |
Why?
|
Genes, Developmental | 1 | 2022 | 39 | 0.050 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2002 | 58 | 0.050 |
Why?
|
Survival Rate | 4 | 2019 | 12761 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2023 | 284 | 0.050 |
Why?
|
Transgenes | 1 | 2005 | 1010 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1762 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2012 | 5959 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 792 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8605 | 0.050 |
Why?
|
Cohort Studies | 5 | 2022 | 40389 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4743 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2002 | 316 | 0.050 |
Why?
|
Hemorheology | 1 | 2020 | 145 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2023 | 486 | 0.050 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2020 | 242 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 364 | 0.050 |
Why?
|
Blood Pressure | 3 | 2021 | 8554 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 695 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12049 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4174 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2002 | 685 | 0.040 |
Why?
|
Brachial Artery | 1 | 2020 | 370 | 0.040 |
Why?
|
Lymphokines | 1 | 2002 | 950 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1359 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 35326 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2021 | 327 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2008 | 9734 | 0.040 |
Why?
|
Mutation | 6 | 2023 | 29658 | 0.040 |
Why?
|
Stroke | 1 | 2021 | 9898 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3692 | 0.040 |
Why?
|
Motion | 1 | 2022 | 803 | 0.040 |
Why?
|
Hypesthesia | 1 | 2018 | 110 | 0.040 |
Why?
|
Rats | 2 | 2012 | 24270 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3344 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2018 | 164 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6516 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 1008 | 0.040 |
Why?
|
Quantitative Trait Loci | 1 | 2005 | 2016 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4332 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6237 | 0.040 |
Why?
|
Sickle Cell Trait | 1 | 2017 | 81 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2017 | 331 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2948 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2017 | 331 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1129 | 0.030 |
Why?
|
Head | 1 | 2022 | 876 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 805 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 879 | 0.030 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3694 | 0.030 |
Why?
|
Anthropometry | 1 | 2020 | 1344 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15194 | 0.030 |
Why?
|
Time Factors | 4 | 2015 | 40050 | 0.030 |
Why?
|
Pol1 Transcription Initiation Complex Proteins | 1 | 2015 | 9 | 0.030 |
Why?
|
Keratin-20 | 1 | 2015 | 31 | 0.030 |
Why?
|
United States | 2 | 2020 | 69573 | 0.030 |
Why?
|
RNA Polymerase I | 1 | 2015 | 24 | 0.030 |
Why?
|
Diet | 1 | 2013 | 7876 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 21694 | 0.030 |
Why?
|
beta-Thalassemia | 1 | 2017 | 224 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1330 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2018 | 1343 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6871 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1585 | 0.030 |
Why?
|
Protein Kinase C-delta | 1 | 2015 | 123 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2021 | 1169 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 552 | 0.030 |
Why?
|
Mandibular Neoplasms | 1 | 2015 | 133 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2015 | 283 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20676 | 0.030 |
Why?
|
Adipokines | 1 | 2016 | 318 | 0.030 |
Why?
|
DNA, Ribosomal | 1 | 2015 | 288 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1849 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1528 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4035 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 808 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 10999 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2015 | 740 | 0.030 |
Why?
|
Immunologic Surveillance | 1 | 2013 | 93 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 853 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2017 | 1528 | 0.030 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2012 | 11 | 0.030 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2012 | 27 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1637 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 338 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1706 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1693 | 0.030 |
Why?
|
Adolescent | 5 | 2020 | 85405 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 62693 | 0.030 |
Why?
|
Maxilla | 1 | 2015 | 459 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2002 | 2933 | 0.030 |
Why?
|
Receptor Cross-Talk | 1 | 2012 | 118 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10455 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12948 | 0.030 |
Why?
|
Random Allocation | 1 | 2016 | 2417 | 0.030 |
Why?
|
Thymus Gland | 1 | 2016 | 1263 | 0.030 |
Why?
|
RNA | 1 | 2021 | 2723 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 779 | 0.020 |
Why?
|
Genotype | 2 | 2020 | 12951 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1296 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1310 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4158 | 0.020 |
Why?
|
Mandible | 1 | 2015 | 736 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 56255 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11347 | 0.020 |
Why?
|
Cell Division | 2 | 2012 | 4575 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2012 | 324 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 643 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4377 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2711 | 0.020 |
Why?
|
Radiosurgery | 1 | 2018 | 1305 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1062 | 0.020 |
Why?
|
Pyrroles | 1 | 2015 | 1142 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3584 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3614 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1356 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 71974 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3606 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2008 | 332 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2749 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23294 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1858 | 0.020 |
Why?
|
S100 Proteins | 1 | 2008 | 259 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5181 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1674 | 0.020 |
Why?
|
Electroencephalography | 1 | 2022 | 6133 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3051 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1539 | 0.020 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2005 | 30 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily A | 1 | 2005 | 21 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13880 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5058 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2005 | 122 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7862 | 0.020 |
Why?
|
Models, Biological | 2 | 2017 | 9609 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2015 | 2583 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7897 | 0.020 |
Why?
|
Antigens, Ly | 1 | 2005 | 292 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2448 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3506 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2005 | 276 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 226 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2019 | 4212 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 38942 | 0.010 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2004 | 215 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2004 | 1088 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 470 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5631 | 0.010 |
Why?
|
Doxycycline | 1 | 2004 | 327 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2005 | 610 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7274 | 0.010 |
Why?
|
Stomatitis | 1 | 2005 | 268 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2004 | 462 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9375 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 2005 | 430 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2005 | 586 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2881 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4555 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
Autoantigens | 1 | 2005 | 891 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8307 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1536 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 773 | 0.010 |
Why?
|
Keratinocytes | 1 | 2004 | 793 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 734 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14740 | 0.010 |
Why?
|
beta Catenin | 1 | 2004 | 1057 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1683 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 1369 | 0.010 |
Why?
|
Ligands | 1 | 2005 | 3311 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 40802 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15987 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2005 | 2515 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2759 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19811 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2131 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13237 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2005 | 3193 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2002 | 3701 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3922 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3863 | 0.010 |
Why?
|
Trans-Activators | 1 | 2004 | 2922 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6726 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5877 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6310 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2639 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5884 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12804 | 0.010 |
Why?
|
Child | 1 | 2020 | 77033 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3802 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3504 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53037 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 6082 | 0.010 |
Why?
|
Apoptosis | 1 | 2005 | 9714 | 0.010 |
Why?
|